Figure 3.
HA, PC-III, IV-C, and LN declined after treatment in the DEB-TACE group (vs. cTACE). Comparison of HA (a), PC-III (b), IV-C (c), and LN (d) at baseline, 1 month after the first TACE, 1 month after the second TACE, and 12 months after the first TACE between the DEB-TACE group and the cTACE group in HCC patients.